Georgetown University
Clinical trials sponsored by Georgetown University, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Can an online sleep program help black prostate cancer survivors get better rest? Results expected Sep 2026 (estimated)
- New hope for AML patients: maintenance chemo combo aims to keep remission going Results expected Dec 2026 (estimated)
- New drug combo shows promise for Hard-to-Treat CLL Results expected Dec 2026 (estimated)
- Could a pill shield hearts from chemo damage? new study investigates Results expected Dec 2026 (estimated)
- Can a Self-Compassion class ease anxiety and depression? new study tests In-Person vs. online Results expected Dec 2026 (estimated)
-
New study aims to cut hormone therapy side effects in prostate cancer
Disease control Not yet recruitingThis study tests a personalized approach to hormone therapy for men with metastatic hormone-sensitive prostate cancer. The goal is to reduce treatment intensity for lower-risk patients to minimize side effects while still controlling the cancer. About 108 participants will receiv…
Phase 2 • Sponsor: Georgetown University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can a compound in grapes help Parkinson's? new trial launches
Disease control Not yet recruitingThis early-phase trial will test whether a special form of resveratrol (JOTROL) is safe and tolerable for people with Parkinson's disease. About 30 participants will receive either a low dose, high dose, or placebo daily for three months. The study will also measure how the drug …
Phase 2 • Sponsor: Georgetown University • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New vaccine combo aims to outsmart ovarian cancer resistance
Disease control Not yet recruitingThis phase 2 trial tests whether a peptide vaccine (NY-ESO-1) combined with an immunotherapy drug (toripalimab-tpzi) can prevent resistance to treatment in 24 women with stage III/IV ovarian cancer that no longer responds to platinum chemotherapy. The vaccine primes the immune sy…
Phase 2 • Sponsor: Georgetown University • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Can a digital guide boost genetic testing in prostate cancer survivors?
Knowledge-focused Not yet recruitingThis study looks at the best way to help prostate cancer survivors learn about and get genetic testing for inherited cancer risks. About 500 participants will be randomly assigned to a digital guide, a printed guide, or standard care. Researchers will track who requests testing a…
Sponsor: Georgetown University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC